Premium
Safety of nontumor necrosis factor‐targeted biologics in the COVID‐19 pandemic
Author(s) -
Akiyama Shintaro,
Yamada Akihiro,
Sakuraba Atsushi
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26528
Subject(s) - medicine , immunology , cytokine storm , adverse effect , pneumonia , rheumatoid arthritis , tumor necrosis factor alpha , pandemic , inflammatory bowel disease , tocilizumab , janus kinase , coronavirus , cytokine release syndrome , disease , cytokine , covid-19 , immunotherapy , immune system , infectious disease (medical specialty) , chimeric antigen receptor